FS KKR Capital Corp. Faces Class-Action Lawsuit Over Alleged Misleading Statements on Portfolio Health

A class-action lawsuit was filed against FS KKR Capital Corp. (NYSE: FSK), a prominent business development company, along with its Chief Executive Officer Michael C. Forman and Chief Financial Officer Steven Lilly. The complaint, filed May 4, 2026, in the U.S. District Court for the Eastern District of Pennsylvania, alleges that the company and its executives made materially false and misleading statements to investors over a nearly two-year period, concealing deteriorating credit quality within its investment portfolio.

The lawsuit, brought on behalf of all individuals and entities that purchased FSK securities between May 8, 2024, and February 25, 2026, seeks to recover damages for alleged violations of federal securities laws. According to the court filing, the defendants are accused of overstating the effectiveness of their portfolio restructuring efforts, the accuracy of portfolio valuations, and the sustainability of the company's shareholder distributions.

The central claim is that while FSK’s management repeatedly assured the market of progress, the underlying health of its investments was worsening. The complaint alleges that for five consecutive quarters, beginning with the announcement of first-quarter 2024 results, CEO Michael C. Forman and other executives painted a picture of stability and improvement. They publicly stated that the company had made “significant progress restructuring certain non-accruing investments” and that the “long-term earnings power of FSK continues to be healthy.” These assurances, plaintiffs contend, created a false sense of security among investors.

This narrative of stability began to unravel on August 6, 2025, when FS KKR Capital reported its second-quarter 2025 financial results. The company revealed that its net asset value (NAV) had declined by $1.44 per share, or 6.2%, from the previous quarter, to $21.93 per share. The total fair value of its investments fell by $474 million. Following this disclosure, the company's stock price fell significantly, dropping $1.66 per share, or 8.2%, to close at $18.58 on August 7, 2025.

A second major blow came several months later. On February 26, 2026, FSK announced it was slashing its quarterly dividend by over 30%, from $0.70 to $0.48 per share. The company also disclosed that its portfolio's non-accrual rates—a key measure of loan health indicating that payments are more than 90 days past due—had risen above the long-term industry average for business development companies. The market reacted swiftly, with FSK’s stock plunging another $2.03 per share, or 15.24%, to close at $11.29 that day. The lawsuit also notes that the fair value of investments fell by another $406 million in the fourth quarter of 2025.

The legal complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. It relies on the fraud-on-the-market presumption, arguing that because FSK stock trades on the New York Stock Exchange and the company makes regular SEC filings, investors relied on the integrity of the market price, which was allegedly inflated by the defendants’ misleading statements. The lawsuit, captioned Stuart v. FS KKR Capital Corp., et al., highlights company statements in SEC filings where the board claimed to oversee portfolio valuations at fair value and asserted that its disclosure controls were effective.

FS KKR Capital Corp. operates as a private credit firm, specializing in making loans and other debt investments in private middle-market U.S. companies. Its primary source of revenue is the interest income from these investments, making the credit quality and valuation of its portfolio critical to its financial performance and stock price. The allegations suggest that the internal processes for valuing these often-illiquid assets and communicating their risks to the public were flawed.

This lawsuit serves as a stark reminder of the immense pressure on publicly traded investment firms to maintain a positive narrative for investors. In our experience, the line between optimistic forecasting and material misrepresentation can become dangerously blurred when portfolio performance falters. For any company, but especially those in the capital markets, transparent and meticulously accurate financial reporting is not just a regulatory requirement; it is the bedrock of investor trust. The allegations against FSK highlight the long-term damage that can occur when that trust is broken. At C&S Finance Group LLC, our work in capital raising and investor strategy emphasizes building sustainable credibility through conservative valuations and clear communication about risks. Proactively managing investor expectations, even when the news is difficult, is always preferable to facing securities litigation and a shattered reputation. Business owners navigating this complex environment can learn more at csfinancegroup.com.

Investors who purchased FSK securities during the class period have until July 6, 2026, to file a motion with the court to be appointed as a lead plaintiff. The court has not yet ruled on class certification. Moving forward, the market will be watching for FS KKR Capital Corp.'s formal response to the allegations and the progression of the case through the Eastern District of Pennsylvania.